Cargando…
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells
High-risk human papillomaviruses (HR-HPVs) are the causative agents for the onset of several epithelial cancers in humans. The deregulated expression of the viral oncoproteins E6 and E7 is the driving force sustaining the progression of malignant transformation in pre-neoplastic lesions. Targeting t...
Autores principales: | Messa, Lorenzo, Celegato, Marta, Bertagnin, Chiara, Mercorelli, Beatrice, Nannetti, Giulio, Palù, Giorgio, Loregian, Arianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902497/ https://www.ncbi.nlm.nih.gov/pubmed/29662081 http://dx.doi.org/10.1038/s41598-018-24470-4 |
Ejemplares similares
-
Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells
por: Celegato, Marta, et al.
Publicado: (2021) -
The Dimeric Form of HPV16 E6 Is Crucial to Drive YAP/TAZ Upregulation through the Targeting of hScrib
por: Messa, Lorenzo, et al.
Publicado: (2021) -
Drug Repurposing for Viral Infectious Diseases: How Far Are We?
por: Mercorelli, Beatrice, et al.
Publicado: (2018) -
Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives
por: Mercorelli, Beatrice, et al.
Publicado: (2011) -
Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on “The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts”
por: Mercorelli, Beatrice, et al.
Publicado: (2019)